sleep disturbance

Menopausal Hot Flashes More Severe in Cancer Survivors

In a recent study comparing hot flashes in 934 cancer survivors (90% of whom had breast cancer) and 155 age-matched control subjects who never had cancer, researches observed that cancer survivors reported more frequent, severe, and troubling hot flashes.

By |2015-08-06T08:56:48-04:00August 20th, 2013|Menopausal Symptoms, Prevalence & Risk Factors|Comments Off on Menopausal Hot Flashes More Severe in Cancer Survivors

New Research from the CWMH: Vasomotor Symptoms Frequently Recur After Discontinuation of SSRI

For the treatment of menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, selective serotonin reuptake inhibitors (SSRIs) are effective and well-tolerated.  Positive effects are observed within 4 weeks of the initiation of treatment.  However, we do not know how long treatment with an SSRI must be continued in order to maintain control of VMS. Nor do we know if VMS will recur after discontinuation of SSRI or if recurrent VMS may be less frequent or less bothersome after receiving SSRI treatment. A recent report from Dr. Hadine Joffe and colleagues at the Center for Women’s Mental Health assessed the recurrence of vasomotor symptoms in women treated with SSRIs.

By |2016-03-28T13:02:52-04:00May 13th, 2013|Menopausal Symptoms, Research at CWMH, Treatment, Vasomotor Symptoms|Comments Off on New Research from the CWMH: Vasomotor Symptoms Frequently Recur After Discontinuation of SSRI

Extended Release Gabapentin (Neurontin) for Hot Flashes

Multiple studies have shown that gabapentin (Neurontin) at 600-2400 mg/day in divided doses is effective for treating hot flashes in menopausal women. This study examines the efficacy of an extended release preparation.

By |2025-12-21T08:42:13-04:00October 21st, 2012|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Extended Release Gabapentin (Neurontin) for Hot Flashes

New Research from the CWMH: Escitalopram and Sleep in Midlife Women with Vasomotor Symptoms

Selective serotonin and serotonin-norepinephrine inhibitors (SSRIs and SNRIs) have been shown to be effective for the treatment of hot flashes.  However, these agents may carry certain side effects, including sexual side effects and sleep disturbance.  These two side effects may be particularly concerning to peri- and postmenopausal women who, in addition to having vasomotor symptoms, are more likely to experience sexual dysfunction and sleep disruption than premenopausal women.

By |2018-06-08T09:03:31-04:00August 20th, 2012|Medication, Menopausal Symptoms, Research at CWMH, Sleep Disorders, Treatment|Comments Off on New Research from the CWMH: Escitalopram and Sleep in Midlife Women with Vasomotor Symptoms

Aerobic Training Improves Menopausal Symptoms and Mood

In this randomized clinical trial, 154 sedentary, symptomatic women were randomly assigned to an aerobic training or a control group. The intervention included unsupervised aerobic training for 50 minutes four times weekly for 24 weeks, whereas the control group attended health lectures twice a month.  Night sweats, mood swings, and irritability were reduced more among the women in the intervention group than in the control group.

By |2015-08-12T16:51:26-04:00March 12th, 2012|Alternative & Complementary, Depressive Disorders, Menopausal Symptoms, Treatment|Comments Off on Aerobic Training Improves Menopausal Symptoms and Mood

Treatment of Insomnia During Pregnancy

Most women experience some degree of sleep disturbance during pregnancy, and for a significant number of women sleep disruption may be quite severe. There are many different causes for sleep disturbance during pregnancy, and choosing the appropriate intervention relies on an accurate diagnosis of the problem.

By |2025-12-11T09:41:07-04:00November 19th, 2007|Pregnancy & Medications, Psychiatric Disorders During Pregnancy, Sleep Disorders|Comments Off on Treatment of Insomnia During Pregnancy

Paroxetine CR May Be Helpful for Menopausal Women Discontinuing Hormone Therapy

Estrogen was first approved by the FDA for the treatment of menopausal symptoms in 1942, and for many decades estrogen replacement therapy had been widely prescribed for peri- and post-menopausal women. In 2002, however, data from the Women’s Health Initiative (WHI) suggested that hormonal therapy may be associated with an increased risk of breast cancer and cardiovascular disease. These findings have led to a dramatic decrease in the use of hormone replacement therapy (HRT), with many women abruptly discontinuing its use.

By |2015-07-28T10:53:58-04:00November 12th, 2007|Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Paroxetine CR May Be Helpful for Menopausal Women Discontinuing Hormone Therapy
Go to Top